Home / LINCOLN.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does LINCOLN.NS make money? Does LINCOLN.NS have pricing power? What's the Earnings Whisper? Will LINCOLN.NS profit more as the business scales? What is LINCOLN.NS's management track record? Is LINCOLN.NS's current price justified?

Lincoln Pharmaceuticals Limited

₹545.6 +$65.80 (+13.71%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹555

Day Range

₹540.7₹559.1

Year Range

₹440₹770

Market Cap

10.93B

AVG Volume

47K

Trailing/Forward PE

11.33/20.31

PEG ratio

0.63

Dividend Yield

0.33%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

LINCOLN.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	7.19B
26 Q4	6.71B
26 Q3	6.52B
26 Q2	6.32B
26 Q1	6.3B
25 Q4	6.23B
25 Q3	5.98B
25 Q2	5.97B
25 Q1	5.92B
24 Q4	5.81B

Net Income (INR) · TTM

LINCOLN.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	964.53M
26 Q4	878.94M
26 Q3	878.34M
26 Q2	800.04M
26 Q1	863.5M
25 Q4	823.46M
25 Q3	893.68M
25 Q2	966.39M
25 Q1	979.63M
24 Q4	933.05M

Operating Income (INR) · TTM

LINCOLN.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	1.46B
26 Q4	831.84M
26 Q3	855.05M
26 Q2	860.69M
26 Q1	894.14M
25 Q4	885.94M
25 Q3	460.83M
25 Q2	524.91M
25 Q1	845.57M
24 Q4	832.22M

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Lincoln Pharmaceuticals Limited

Video analysis: LINCOLN.NS

News: LINCOLN.NS

Similar companies